3 Cheap Dividend Stocks (Down Over 30%) to Buy in January 2023

Given their discounted stock prices and high yields, these three cheap dividend stocks could be attractive for income-seeking investors.

| More on:

After a tough last year, the Canadian equity markets have made a solid beginning to 2023, with the S&P/TSX Composite Index rising 6.9%. Despite the recent improvement, few stocks are trading at a substantial discount from their 52-week highs. The following three dividend stocks are trading at over a 30% discount from their 52-week highs, thus offering excellent buying opportunities for income-seeking investors.

Algonquin Power & Utilities

Algonquin Power & Utilities (TSX:AQN), which has taken a severe beating in the last few months, is my first pick. Rising interest rates, high net losses in the recently reported third-quarter earnings, and lower earnings guidance appear to have dragged its stock price down. Amid the challenging environment, the company cut its quarterly dividends by 40% to US$0.1085/share. Despite the dividend cut, its yield for the next 12 months stands at a healthy 5.95%.

Despite the U.S. Federal Energy Regulatory Commission (FERC) denying the approval to acquire Kentucky Power, AQN is continuing its acquisition efforts. The company sells around 80% of its power produced from its renewable assets through long-term contracts, which provides visibility on its future earnings. It is also working on lowering its debt through asset sales. Also, its solid track record and attractive NTM (next 12-month) price-to-earnings ratio of 12.2 make AQN an attractive buy in this volatile environment.

TransAlta Renewables

TransAlta Renewables (TSX:RNW) has lost 36.9% of its stock value compared to its 52-week high amid the rising interest rates and weakness in the renewable energy space. The company operates a diversified portfolio of hydro, wind, solar, and natural gas facilities across Canada, the United States, and Australia. Amid the challenging environment, the company’s management has announced that it would focus on dividend sustainability in the near term rather than acquisitions. This announcement appears to have weighed on investors’ sentiments, leading to a selloff.

Meanwhile, TransAlta Renewables expects to put a few renewable and transmission assets in Australia into service this year. It also hopes to bring back Kent Hills facilities into service in the second half of this year. So, the management believes that its cash flows are resilient. The company hopes to post an adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $495-$535 million in 2023, which is slightly higher than its 2022 guidance.

Amid the selloff, TransAlta Renewables’s NTM price-to-earnings ratio has declined to 15.4, while its dividend yield stands at a juicy 7.66%, making it an attractive buy.

NorthWest Healthcare Properties REIT

With a dividend yield of 7.9%, NorthWest Healthcare Properties REIT (TSX:NWH.UN) is my final pick. REITs (real estate investment trusts) have taken a severe beating over the last few months due to rising interest rates. Amid the weakness, the company is trading at a 30% discount from its 52-week high. Amid the steep correction, the company’s price-to-book ratio has declined to one.

Meanwhile, the company had entered a joint venture with an institutional investor in the United Kingdom to expand its footprint in the United Kingdom healthcare real estate space. Its diversified portfolio, long-term lease agreements, high-quality tenants (with government support), and inflation-indexed rents provide financial stability. So, I believe the company’s payouts are safe, thus making the stock attractive, despite the volatility.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool recommends NorthWest Healthcare Properties Real Estate Investment Trust. The Motley Fool has a disclosure policy.

More on Dividend Stocks

Train cars pass over trestle bridge in the mountains
Dividend Stocks

Is CNR Stock a Buy, Sell, or Hold for 2025?

Can CNR stock continue its long-term outperformance into 2025 and beyond? Let's explore whether now is a good time to…

Read more »

coins jump into piggy bank
Dividend Stocks

The Smartest Dividend Stocks to Buy With $500 Right Now

These top dividend stocks both offer attractive yields and trade off their highs, making them two of the best to…

Read more »

Middle aged man drinks coffee
Dividend Stocks

Here’s the Average TFSA Balance at Age 35 in Canada

At age 35, it might not seem like you need to be thinking about your future cash flow. But ideally,…

Read more »

ETF stands for Exchange Traded Fund
Dividend Stocks

How to Invest Your $7,000 TFSA Contribution in 2024

Here's how I would prioritize a $7,000 TFSA contribution for growth and income.

Read more »

a man relaxes with his feet on a pile of books
Dividend Stocks

CPP Pensioners: Watch for These Important Updates

The CPP is an excellent tool for retirees, but be sure to stay on top of important updates like these.

Read more »

Technology
Dividend Stocks

TFSA Investors: 3 Dividend Stocks I’d Buy and Hold Forever

These TSX dividend stocks are likely to help TFSA investors earn steady and growing passive income for decades.

Read more »

four people hold happy emoji masks
Dividend Stocks

Love Dividend Growth? Check Out These 2 Income-Boosting Stocks

National Bank of Canada (TSX:NA) and another Canadian dividend-growth stock are looking like a bargain going into December 2024.

Read more »

An investor uses a tablet
Dividend Stocks

A Dividend Giant I’d Buy Over Enbridge Stock Right Now

Enbridge stock may seem like the best of the best in terms of dividends, but honestly this one is far…

Read more »